KPL Kepler Group Ltd

NEUTRAL Impact: 5/10 F-1
Horizon weeks Filed May 22, 2026 Processed 18d 10h ago SEC 0001493152-26-025069
Foreign IPO registration

Executive Summary

Kepler Group Ltd, a Hong Kong-based insurance broker, files its F-1 registration statement for an initial public offering of 5,000,000 ordinary shares on Nasdaq (symbol KPL) at an expected price range of $6-$8 per share, upsized from a prior amendment that contemplated 1.4 million shares at $4-$6. The company generated revenue of $20.3 million (HK$157.4 million) for the fiscal year ended March 31, 2025, up 9.6% year-over-year, but net income declined 17.3% to $0.85 million. Proceeds of approximately $30.5 million (midpoint) are earmarked for U.S. and Southeast Asian expansion, digital platform development, and working capital. Regulatory risks related to Hong Kong/PRC oversight and the HFCA Act are highlighted.

Key Financial Metrics

Price Range
$6-$8 per share

Actionable Insight

Monitor final IPO pricing and first-day trading for price discovery. The upsized offering and higher price range suggest growing underwriter confidence, but net income decline and regulatory overhangs (PRC/HK, HFCA) warrant caution. Watch for post-listing liquidity, lock-up expirations, and any CSRC filing requirements.

Key Facts

  • Offering 5,000,000 ordinary shares at $6-$8 per share, upsized from prior 1.4M shares at $4-$6
  • Estimated net proceeds of ~$30.5 million at midpoint
  • FY2025 revenue $20.3M (HK$157.4M), +9.6% YoY; net income $0.85M (HK$6.6M), -17.3% YoY
  • Six months ended Sep 30, 2025: revenue $24.7M, net income $1.1M
  • No VIE structure; Cayman Islands holding company with Hong Kong operating subsidiaries
  • Top five insurance product providers account for ~74.7% of revenue
  • Post-IPO, founder Kwok Yu Hin will own 54.53% of shares; controlled company
  • Listing on Nasdaq Capital Market under symbol KPL
  • Auditor Onestop Assurance PAC is PCAOB-inspected; HFCA Act delisting risk disclosed

Financial Impact

IPO raises up to $35.3M (including over-allotment) at $7 midpoint

revenuenet incomedilution

Risk Factors

  • Regulatory uncertainty from PRC/HK government oversight and potential HFCA Act delisting
  • Concentration risk: top five product providers represent ~75% of revenue
  • Controlled company structure with founder holding 54.53% post-IPO
  • Historical net income decline of 17.3% in FY2025 despite revenue growth
  • Dependence on channels (referrers and consultants) for customer acquisition
  • Limited public float may exacerbate volatility

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
F-1 Filing (Primary)0001493152-26-025069
Exhibit: ex3-2.htm0001493152-26-025069
Exhibit: ex3-1.htm0001493152-26-025069

US Market Status

Market Closed — Opens in 5h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access